ED/I  Kansas Bioscience Authority

http://www.kansasbioauthority.org





     Office Locations:

10900 S. Clay Blair Blvd.
Olathe, KS 66061
Phone: 913-397-8300

 

Stages:

  • Early
  • Seed


 

Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    The Kansas Bioscience Authority was established by the state legislature in 2004 to help grow the bioscience sector into a pillar of the Kansas economy. The Kansas Bioscience Authority is looking to selectively partner with bioscience companies, inventors, entrepreneurs and investment professionals to substantially advance the state's vibrant bioscience industry. To be eligible, a company's primary business must be providing a bioscience process, product or service and the company owns, has filed for, or has a license to use protected, proprietary intellectual property, and the management or working founders must have at least $25,000 cash investment in the company. The Venture Accelerator is a 39,000-square-foot, Gold LEED-certified facility custom designed to serve emerging bioscience organizations looking to successfully take their discoveries to market. Situated in the KC Animal Health Corridor and in the 92-acre Kansas Bioscience Park in Olathe, the incubator has convenient access to interstate highways.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Duane Cantrell President & CEO
    Keith Harrington Managing Director
    Kevin Lockett CFO & COO
    Tom Krol Managing Director
    Tony Simpson Managing Director

     

    Portfolio companies include:


      Aratana Therapeutics
        web link


      FlowForward Medical
        web link


      Green Dot
        web link


      Health Outcomes Sciences
        web link


      HOS


      Innara Health
        web link


      Metactive Medical
        web link


      Oncimmune
        web link


      SmartVet
        web link


     

    Recent News:


      There is no recent news for Kansas Bioscience Authority.